Comment on: The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass

Surg Obes Relat Dis. 2022 May;18(5):e30-e31. doi: 10.1016/j.soard.2022.01.016. Epub 2022 Jan 31.

Authors

Jacqueline A Murtha¹, David A Harris², Luke M Funk²

Affiliations

¹ Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin.
² Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin; William S. Middleton Memorial Veterans Administration Hospital, Madison, Wisconsin.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Gastrectomy
Gastric Bypass*
Humans
Laparoscopy*
Obesity, Morbid* / surgery
Pyrazoles / therapeutic use
Pyridones / therapeutic use
Treatment Outcome

Substances

Pyrazoles
Pyridones
apixaban

Grants and funding

T32 DK007665/DK/NIDDK NIH HHS/United States